- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 14, 2025 | 1.81M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $2.26M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.17M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.29M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.28M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $3.6M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.77M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.86M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.71M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $6.17M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $7.15M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 47.58K sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.2M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$2.55M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$1.53M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$53.00 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$53.00 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.06M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $607.23K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.54M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$2.48M |
| Revenue | Q1 2025 · Mar 31, 2024 | $5.6K |